International Stem Cell Revenue

In the year 2024, International Stem Cell had annual revenue of $9.09M with 16.64% growth. International Stem Cell had revenue of $2.45M in the quarter ending December 31, 2024, with 29.49% growth.

Revenue

9.09M

Revenue Growth

+16.64%

P/S Ratio

0.10

Revenue / Employee

283.91K

Employees

Market Cap

880.48K

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	9.09M	1.30M	16.64%
Dec 31, 2023	7.79M	-391.00K	-4.78%
Dec 31, 2022	8.18M	1.00M	13.99%
Dec 31, 2021	7.18M	48.00K	0.67%
Dec 31, 2020	7.13M	-2.34M	-24.75%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Endo Inc.	1.76B
Veradigm	588.02M
Tian'an Technology Group	1.78M
Glass House Brands	200.90M
Elite Pharmaceuticals	70.00M
Northwest Biotherapeutics	1.38M
BioStem Technologies	301.83M
American Oncology Network	1.76B

Revenue Rankings

International Stem Cell News

5 weeks ago - International Stem Cell GAAP EPS of -$0.03, revenue of $9.09M - Seeking Alpha
5 weeks ago - International Stem Cell Corporation Announces 2024 Fourth Quarter and Year-End Results - Accesswire
1 year ago - Eighteenth edition of Fujio Cup Quiz won by Kasturba Medical College, India in the NCRM NICHE 2023 international stem cell meeting. - Business Wire
3 years ago - International Stem Cell Corporation Announces Strong Financial Results for the Quarter Ended March 31, 2022 - Accesswire

More News